Maha Saber-Ayad

23PUBLICATIONS
42CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples diet and nutritionMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 24, 2026
Disruption of Mitophagy-Related Gene Expression in Gestational Diabetes Mellitus: A Transcriptomic and Machine Learning Approach.

Souhaib Bouati, Shaima Ameen, Nour Al Dain Marzouka

|Jan 28, 2026
Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408.

Khuloud Bajbouj, Rizwan Qaisar, Mohammed A Alshura

|Jun 09, 2025
Characterizing Genetic, Epigenetic, Nutritional, and Clinico-Biochemical Profile of Women With Polycystic Ovary Syndrome: A Case-Control Study.

Woroud M-Majd Chaker, Raghda Mohammed Adi, Mohamed Madkour

|Apr 25, 2025
Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy.

Fatima I AlMaazmi, Lara J Bou Malhab, Leen ElDohaji

|Jul 08, 2024
Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.

Amina Jamal Laham, Raafat El-Awady, Maha Saber-Ayad

|Jun 05, 2024
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.

Amina Jamal Laham, Raafat El-Awady, Maha Saber-Ayad

Pageof 4

Frequent Collaborators

4 joint publications

Khuloud Bajbouj

3 joint publications

Qutayba Hamid

3 joint publications

Eman Abu-Gharbieh

2 joint publications

Zeinab Ibrahim